ENHERTU® Plus Pertuzumab Approved in the U.S. as First New Treatment in More Than a Decade ...

ENHERTU Plus Pertuzumab Approved in the U.S. for First-Line Treatment of Patients with HER2 Positive Metastatic Breast Cancer ...

3 Altcoins Facing Liquidation Risks in the Third Week of December

Altcoins face heightened liquidation risks as fear dominates markets, with SOL, ADA, and PIPPIN under pressure.

Intel Receives $16 Billion Investment Boost, But Yield And Execution Challenges Persist

Intel received major investments from SoftBank, Nvidia, and the US government, signaling strong external confidence but ...

IYM: Materials Dashboard For December

The iShares U.S. Basic Materials offers capital-weighted exposure to Russell 1000 materials companies but is less compelling ...
Financial Planning

How to unbox tax savings with a four-sided options strategy

An increasingly popular form of lending enables financial advisors and their clients to offset capital gains and find other ...